EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Neuroprotective effect of cedrol in a male rat model of Parkinson's disease

Fatemeh Forouzanfar iD, Mahmoud Hosseini iD, Amir Mahmoud Ahmadzadeh, Ali Mohammad Pourbagher-Shahri

Physiological Reports · 2025

DOI: 10.14814/phy2.70309 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Fatemeh Forouzanfar and 3 co-authors. Institution: Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Major MEDLINE topics: Neuroprotective Agents, Parkinson Disease. Cited 9 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Mashhad University of Medical Sciences (MUMS).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cedrol is a natural sesquiterpene subgroup of terpenes with antioxidant and anti‐inflammatory properties. This study evaluated the effect of cedrol on the 6‐hydroxydopamine (6‐OHDA) rat model of Parkinson's disease (PD). Unilateral injection of 6‐OHDA was performed to induce the PD model. Cedrol at 10 mg/kg and 20 mg/kg was administrated. The rotarod test, apomorphine‐induced rotational test, and open field tests assessed motor function, while the passive avoidance test was used to evaluate cognitive function. Furthermore, striatal levels of malondialdehyde (MDA) and total thiol, and SOD (superoxide dismutase) activity were measured. The induction of lesion led to a significantly higher number of rotations in the apomorphine‐induced rotational test, lower maintenance in the rotarod test, as well as a shorter delay for entering into and a longer duration of time spent in the dark chamber in the passive avoidance test, versus the control group. It also enhanced the striatal levels of MDA and diminished the striatal SOD activity and level of total thiol. Administration of cedrol significantly improved behavioral tests and biochemical assays. Cedrol could benefit cognitive and motor functions in a rat model of PD. Its antioxidant properties might mediate these effects.

Subjects

MeSH terms (MEDLINE)

Neuroprotective AgentsParkinson DiseaseAnimalsMaleRatsOxidopamineSuperoxide DismutaseDisease Models, AnimalMalondialdehydeRats, WistarCorpus StriatumMotor ActivityBehavior, AnimalAvoidance Learning

Author keywords

Parkinson diseasecedrolherbal medicineneurodegenerative disordersesquiterpene

Substances

Neuroprotective AgentsOxidopamineSuperoxide DismutaseMalondialdehyde

Authors and institutions

  • Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Radiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID profiles: Fatemeh Forouzanfar, Mahmoud Hosseini

Funding

  • Mashhad University of Medical Sciences (MUMS)

Cite

APA

Forouzanfar, F., Hosseini, M., Ahmadzadeh, A. M., & Pourbagher-Shahri, A. M. (2025). Neuroprotective effect of cedrol in a male rat model of Parkinson's disease. Physiological Reports. https://doi.org/10.14814/phy2.70309

Vancouver

Forouzanfar F, Hosseini M, Ahmadzadeh AM, Pourbagher-Shahri AM. Neuroprotective effect of cedrol in a male rat model of Parkinson's disease. Physiological Reports. 2025. doi:10.14814/phy2.70309

BibTeX
@article{Forouzanfar2025,
  author = {Forouzanfar, Fatemeh and Hosseini, Mahmoud and Ahmadzadeh, Amir Mahmoud and Pourbagher-Shahri, Ali Mohammad},
  title = {Neuroprotective effect of cedrol in a male rat model of Parkinson's disease},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70309}
}
Start for free →